Eligibility criteria expanded, about 13 words
Secondary endpoints: details revised at 3 of 3 entries; Study description expanded, about 13 words; Publications: details revised at 4 of 4 entries
Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00009243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialThe 50 most recent of 362 record versions are accounted for below. See every version on ClinicalTrials.gov ↗
Eligibility criteria expanded, about 13 words
Secondary endpoints: details revised at 3 of 3 entries; Study description expanded, about 13 words; Publications: details revised at 4 of 4 entries
39 amendments
39 re-verifications since 2025-08-22, no change to tracked fields
v323-v361
Site contacts updated at 2 of 3 sites
Study Status, Conditions, Eligibility, Contacts/Locationsv322
6 amendments
6 re-verifications since 2025-04-30, no change to tracked fields
v316-v321
Enrollment target: 3000 to 4000
Study Status, Study Designv315
2 amendments
2 re-verifications since 2025-03-19, no change to tracked fields
v313-v314
| NCT Number | NCT00009243 |
| Lead Sponsor | National Institute of Neurological Disorders and Stroke (NINDS) |
| Conditions | Brain Disease, Ischemic Attack, Transient, Cerebrovascular Accident, Cerebrovascular Disorder, Vascular Diseases |
| Enrollment | 4,000 participants |
| Start Date | |
| Updated on ClinicalTrials.gov |